https://www.bloomberg.com/news/arti...its-fda-panel-as-furor-over-biogen-drug-grows
The third committee member to quit after the Biogen approval.
The problem has to do with approving the drug on too little solid evidence. Hopefully it will cause the FDA to rethink the soft approach to prematurely approving treatments that really haven't achieved success in properly conducted confirmatory RCTs.
- Forums
- ASX - By Stock
- MSB
- Alzheimer drug approved
Alzheimer drug approved, page-241
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.00 |
Change
0.010(1.01%) |
Mkt cap ! $1.158B |
Open | High | Low | Value | Volume |
99.5¢ | $1.02 | 98.5¢ | $1.558M | 1.551M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 100990 | 99.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.00 | 41706 | 35 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 104719 | 0.995 |
16 | 145990 | 0.990 |
11 | 125455 | 0.985 |
11 | 168256 | 0.980 |
3 | 502841 | 0.975 |
Price($) | Vol. | No. |
---|---|---|
1.000 | 59081 | 30 |
1.005 | 46935 | 13 |
1.010 | 87584 | 10 |
1.015 | 85090 | 9 |
1.020 | 117593 | 12 |
Last trade - 12.34pm 15/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online